Peer Review History
| Original SubmissionJuly 16, 2021 |
|---|
|
PONE-D-21-14725 Identifying content to improve risk assessment communications within the Risk Profile: Rapid literature reviews and Focus groups with expert and non-expert stakeholders PLOS ONE Dear Dr. Ellermann, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected. Specifically, the methods does not satisfy the standards of PLOS ONE. I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision. Yours sincerely, Tim Mathes Academic Editor PLOS ONE Additional Editor Comments (if provided): Unfortunately, we cannot consider the manuscript for publication because the methodology does not satisfy the methodological standards of PLOS ONE. The main methodological concerns are: - The approach or methods for initial search step are not described. - I is not clear were the systematic review process has been rapid, i.e. what and where shortcuts were made, and what is the rational. - It is quite unusual to synthesizes secondary (systematic reviews) and primary studies (RCTs), unless existing systematic reviews are out-dated (e.g. with new RCTs) and the primary studies are only used to supplement the systematic reviews. - The literature search is technical flawed. Relevant MeSH-terms and keywords are missing. - AMSTAR (1) was used although AMSTAR 2 already existed at the time of the assessment. In addition, it is not adequate to calculate an overall score for AMSTAR. - Only experts from one institution were included in the focus groups. - The sampling strategy and sample characteristics of the population are not described and thus it cannot be assessed if the sample is representative. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] - - - - - For journal use only: PONEDEC3 |
| Revision 1 |
|
PONE-D-21-14725R1Identifying content to improve risk assessment communications within the Risk Profile: Literature reviews and Focus groups with expert and non-expert stakeholdersPLOS ONE Dear Dr. Ellermann, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 05 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Tim Mathes Academic Editor PLOS ONE Journal Requirements: 1. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. 2. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 5. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A Reviewer #3: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: No Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The paper addresses a specific case related to BfR's role and work in Germany in the continuous development of comprehensible risk communication. The background, as inferred by the paper, is that different target groups involved in the risk communication chain have different views on importance, content, and outcome of the communication. In this paper qualitative focus group methodology has been used to gather in-depth insights into aspects of the Risk Profile that may improve risk messaging. As such qualitative methodology does not provide generalisable results or knowledge of how a topic is understood in the general or target population. However, by taking certain precautions in the recruitment of respondents, valuable input and insight can be provided. The paper addresses these issues in a satisfactory way. I have one question: Is the qualitative evaluation of the 2013 Risk Profile conducted in 2015 published somewhere? Reviewer #2: This is an interesting paper with the aim of improving the presentation methods for risk profiles on foods and consumer products as provided by risk assessment agencies. I believe this is an important area of development given the target audiences of these assessments and the increasing interest in science communication. The methods used are appropriate and generally well reported. It was a pleasure to review this manuscript. I have a few specific comments on the manuscript, which I hope are helpful. General note: Some parts of the manuscript seem unnecessarily lengthy in my opinion, e.g. the explanation of a PICO in S1 (section 2.1) and of the search techniques (use of thesaurus, key words, Boolean Operators). I don’t think it is necessary to describe standard review methods as long as it is reported in a transparent and reproducible way what was specifically done in the given review (e.g. reporting of the PICO elements, databases searched, search strategy etc.). I think it would make the paper more digestible to abbreviate such passages, but I understand that such choices can be deliberate depending on the audience. Background: In line 87/88 you refer to “EFSA explains” factsheets targeted at consumer audiences. This seems contradictory to step 1 (lines 209/10), where you state that searches for risk communication strategies used by international agencies did not yield any applicable results. Furthermore, you mention that there were some exceptions to this (line 211). It would be interesting to know whether and how these were considered or – if not – why they were not deemed relevant. Lastly, were there any relevant differences between the 2013 BfR version of the Risk Profile and the adapted Swedish “risk thermometer” that may have been relevant to advancing the BfR tool? In line 94, you mention formats to disseminate findings from systematic reviews to non-expert audiences such as plain language summaries. However, it appears that reference 9 and 10 refer to studies conducted with health professionals or researchers. This seems misleading and I believe that there are better suited references, e.g. doi:10.1016/j.jclinepi.2014.04.009. Methods/Results: Line 235: I suggest rephrasing this. As I understand, you searched systematic reviews and trials on the effects of different communication strategies, not “current best practice recommendations” (e.g. as provided here: 10.1136/bmjopen-2019-036348). Also check line 400 on this. Lines 247 ff: It should be mentioned here that not all the listed databases were searched for all key questions. In the main manuscript it would be useful to state whether the focus group members received the Risk Profile beforehand. I did not find this information. The final version of the Risk Profile on magnesium is an example with a verbal presentation of risks. It would be interesting to see an example where adverse effects are presented numerically. Discussion: The limitations section is relatively short and could address more issues. One limitation, for example, is that prototype V2 was not reassessed with risk managers and the members of the public. Thus, I am not sure the process is truly iterative. A second round could have highlighted additional information – for example (I am just thinking loudly here), how people feel about the presentation of the likelihood of occurrence for a low intake (vs. high intake or presentation of both). Also, the interview guide provided in S3 seems ambitious for 1.5 to 2h focus groups. It would be interesting to reflect on this and whether there were topics that could not be addressed due to time constraints, especially among members of the public not familiar with the topic. One important aspect of communication is the distribution of the information. This receives little attention in the manuscript. It would be interesting to discuss this aspect. To name one example, social media and mobile devices are major channels for infographics, but have specific requirements (size constraints, limited attention, “mobile first” etc.). Thus, the Risk Profiles would likely need to be modified for such purposes. The discussion provides an opportunity to highlight this limitation and opportunity for future work. Supplement 1: The numbers in Figure 1 deviate from the numbers in the preceding text (e.g. figure 1 reports 4 additional records identified from gray literature, whereas the text passage mentions three records identified through Google Scholar, 406 at ti/ab stage in figure vs. 405 in text and so on). It also seems odd that there are duplicates, even though only one database was searched. Have you checked that this was not an error from the automated deduplication in EndNote? There also seem to be errors in the other flow charts in S1 (e.g. page 15: 161, 66, 76 and 93 records equate to 396, while the figure reports 391 initial records). Please make sure the numbers throughout the manuscript and supplements are correct and consistent. Minor: Line 90: should it say “to health”? Line 92: the semicolon after Cochrane Collaboration seems to be superfluous Line 137: I think the comma after “managers” is not needed Line 175: “initial first step” seems tautologic Line 225: consider removing “all” References: Please check the references for correct citation style. There seem to be some errors here, e.g. reference 7 (publisher missing) and 14 (first names of authors written out, “and” between authors). Reviewer #3: I was glad to have the opportunity to review this manuscript, as risk communication research as a whole does need to be improved starting actually from the communication of risk assessment process and results, that to be effective, needs to be crafted according to several factors and this paper well shows this complexity. The very first step to have food risks appropriately perceived and managed – both by risk manages and consumers – is to translate the output of the risk assessment into relevant, understandable, reliable, clear and possibly “operational” information/instruction to face that risk. Therefore, I warmly recommend the publication of this work; as well I encourage the authors to conduct additional research to fix the underlined criticalities, as stated in the Discussion session (line 406). This is an important result that emerges from this work. In addition, this work (the risk profile tool) has the potential to be adopted by the wider community of risk communication practitioners, and serve as a tools for example to make comparisons between countries in terms of use, understanding and increasing of risk communication efficacy to both risk managers and consumers. Before publication, I would suggest some little changes. The paper is well written but I think that some little improvements could be done - Line 97: a general definition of risk profile should be given (what is it? What is it meant for? What content/information should it deliver? Who prepares a risk profile?...); I understand that is resembles the description of the BfR risk profile and that this can be inferred from the text, but it is better to provide the reader with a general / ideal one and this study helped to find the best working one so far. See for example section 3.3 in EFSA’s Technical assistance in the field of risk communication https://efsa.onlinelibrary.wiley.com/doi/pdf/10.2903/j.efsa.2021.6574 - Line 176: how did you perform this task? Keywords used, websites/search engines searched, … - Line 199: you mention here the “user-guide on how to complete the risk profile”: did you produce it as an output of Step 4? I don’t understand whether the “user-guide” is the risk profile template without information, simply the grid, or it is something different, e.g. a text that helps (guides) risk assessors to fill in the risk profile template with all the information needed? - Line 311: step 3: which risk profile versions were discussed? Although your work is very detailed, it is difficult to seek for information through the main text and the supplementary materials, and the reader gets lost or does not easily remember each step of the methodology and the materials used at every given moment. - Focus group results: did you consider creating a final table/figure to summarize focus group results to highlight common suggestions and discrepancies? I understand that the interview guides were different for each target audience, but the categorisation of results could help you draw a final map with major findings ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Identifying content to improve risk assessment communications within the Risk Profile: Literature reviews and Focus groups with expert and non-expert stakeholders PONE-D-21-14725R2 Dear Dr. Ellermann, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Tim Mathes Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: N/A Reviewer #3: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: (No Response) Reviewer #3: The peer review process definitely improved the quality of the manuscipt, that was already well written and reported a well executed study. I definitely agree for publication. I only have one remark, concerning Fig. 2 If I am correct, there should be 4 steps in the figures, as the reader can find 4 steps in the manuscript (both Methods and Results sections). ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Roland Brian Büchter Reviewer #3: Yes: Barbara Tiozzo |
| Formally Accepted |
|
PONE-D-21-14725R2 Identifying content to improve risk assessment communications within the Risk Profile: Literature reviews and Focus groups with expert and non-expert stakeholders Dear Dr. Ellermann: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Tim Mathes Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .